Novel motif:113: Difference between revisions
From FANTOM5_SSTAR
No edit summary |
No edit summary |
||
(2 intermediate revisions by the same user not shown) | |||
Line 1: | Line 1: | ||
{ |
Latest revision as of 15:08, 9 September 2013
name: | motif113_YGAGCTRTG |
---|
Association to promoter expression in human samples<b>Summary:</b>Significance of the correlation with CAGE expression, human <br><b>Analyst:</b> Michiel de Hoon<br><br>link to source dataset <br>data
Association to promoter expression in mouse samples
<b>Summary:</b>Significance of the correlation with CAGE expression, mouse <br><b>Analyst:</b> Michiel de Hoon<br><br>link to source dataset <br>data
GREAT analysis results for human
<b>Summary:</b>Genomic Enrichment of Annotations Tool (GREAT, Nat Biotechnol. 2010 May;28(5):495-501) is used to identify, both in human and in mouse, the gene ontology terms of biological processes enriched given the predicted TFBSs, and evaluated the overlap in the top-500 gene ontology terms between human and mouse. For each novel motif, the P value for the overlap was then evaluated by calculating its relative rank with respect to this background distribution.<br>Analyst: Michiel de Hoon<br><br>link to source dataset <br>data
GO ID | GO Term | p-value |
---|---|---|
GO:0033572 | transferrin transport | 2.154145e-12 |
GO:0046500 | S-adenosylmethionine metabolic process | 3.503826e-8 |
GO:0045007 | depurination | 7.878207e-8 |
GO:0002577 | regulation of antigen processing and presentation | 1.538575e-7 |
GO:0006826 | iron ion transport | 6.986785e-7 |
GO:0031440 | regulation of mRNA 3'-end processing | 8.036405e-7 |
GO:0007035 | vacuolar acidification | 1.007635e-6 |
GO:0070932 | histone H3 deacetylation | 1.125275e-6 |
GO:0001502 | cartilage condensation | 1.382018e-6 |
GO:0002579 | positive regulation of antigen processing and presentation | 1.704422e-6 |
GO:0043542 | endothelial cell migration | 2.034271e-6 |
GO:0006556 | S-adenosylmethionine biosynthetic process | 2.480096e-6 |
GO:0031442 | positive regulation of mRNA 3'-end processing | 3.150406e-6 |
GO:0046129 | purine ribonucleoside biosynthetic process | 3.308374e-6 |
GO:0002604 | regulation of dendritic cell antigen processing and presentation | 4.042336e-6 |
GO:0070933 | histone H4 deacetylation | 5.505327e-6 |
GO:0010107 | potassium ion import | 7.016713e-6 |
GO:0014874 | response to stimulus involved in regulation of muscle adaptation | 8.964219e-6 |
GO:0010987 | negative regulation of high-density lipoprotein particle clearance | 9.612460e-6 |
GO:0010897 | negative regulation of triglyceride catabolic process | 9.612460e-6 |
GO:0018095 | protein polyglutamylation | 1.045522e-5 |
GO:0046394 | carboxylic acid biosynthetic process | 1.083798e-5 |
GO:0048505 | regulation of timing of cell differentiation | 1.206696e-5 |
GO:0050684 | regulation of mRNA processing | 1.347589e-5 |
GO:0034983 | peptidyl-lysine deacetylation | 1.447296e-5 |
GO:0045820 | negative regulation of glycolysis | 1.571093e-5 |
GO:0009155 | purine deoxyribonucleotide catabolic process | 2.177784e-5 |
GO:0009151 | purine deoxyribonucleotide metabolic process | 2.287508e-5 |
GO:0034465 | response to carbon monoxide | 2.743569e-5 |
GO:0042866 | pyruvate biosynthetic process | 3.165341e-5 |
GO:0030327 | prenylated protein catabolic process | 3.235023e-5 |
GO:0001990 | regulation of systemic arterial blood pressure by hormone | 3.402907e-5 |
GO:0046654 | tetrahydrofolate biosynthetic process | 3.423099e-5 |
GO:0050760 | negative regulation of thymidylate synthase biosynthetic process | 4.252513e-5 |
GO:0030826 | regulation of cGMP biosynthetic process | 4.376671e-5 |
GO:0010989 | negative regulation of low-density lipoprotein particle clearance | 4.835012e-5 |
GO:0030201 | heparan sulfate proteoglycan metabolic process | 5.266043e-5 |
GO:0090072 | positive regulation of sodium ion transport via voltage-gated sodium channel activity | 5.338205e-5 |
GO:0045355 | negative regulation of interferon-alpha biosynthetic process | 5.444084e-5 |
GO:0014916 | regulation of lung blood pressure | 6.267808e-5 |
GO:0051241 | negative regulation of multicellular organismal process | 6.890657e-5 |
GO:0006029 | proteoglycan metabolic process | 6.898778e-5 |
GO:0010982 | regulation of high-density lipoprotein particle clearance | 7.263564e-5 |
GO:0035725 | sodium ion transmembrane transport | 7.416093e-5 |
GO:0015991 | ATP hydrolysis coupled proton transport | 7.501907e-5 |
GO:0034767 | positive regulation of ion transmembrane transport | 7.524952e-5 |
GO:0003300 | cardiac muscle hypertrophy | 7.868720e-5 |
GO:0055012 | ventricular cardiac muscle cell differentiation | 8.233352e-5 |
GO:0003081 | regulation of systemic arterial blood pressure by renin-angiotensin | 9.654945e-5 |
GO:0009712 | catechol-containing compound metabolic process | 9.683710e-5 |
GO:0061072 | iris morphogenesis | 9.800768e-5 |
GO:0010509 | polyamine homeostasis | 1.013383e-4 |
GO:0046642 | negative regulation of alpha-beta T cell proliferation | 1.080134e-4 |
GO:0002606 | positive regulation of dendritic cell antigen processing and presentation | 1.092971e-4 |
GO:0046628 | positive regulation of insulin receptor signaling pathway | 1.298717e-4 |
GO:0070613 | regulation of protein processing | 1.305825e-4 |
GO:0038028 | insulin receptor signaling pathway via phosphatidylinositol 3-kinase cascade | 1.321840e-4 |
GO:0009308 | amine metabolic process | 1.333724e-4 |
GO:0032488 | Cdc42 protein signal transduction | 1.334036e-4 |
GO:0045606 | positive regulation of epidermal cell differentiation | 1.340221e-4 |
GO:0009309 | amine biosynthetic process | 1.471619e-4 |
GO:0002740 | negative regulation of cytokine secretion involved in immune response | 1.514715e-4 |
GO:0006584 | catecholamine metabolic process | 1.519754e-4 |
GO:0006349 | regulation of gene expression by genetic imprinting | 1.637816e-4 |
GO:0051788 | response to misfolded protein | 1.751259e-4 |
GO:0050913 | sensory perception of bitter taste | 1.780960e-4 |
GO:0007166 | cell surface receptor linked signaling pathway | 1.785864e-4 |
GO:0031272 | regulation of pseudopodium assembly | 1.831200e-4 |
GO:0032695 | negative regulation of interleukin-12 production | 1.953063e-4 |
GO:0006913 | nucleocytoplasmic transport | 2.066999e-4 |
GO:0002922 | positive regulation of humoral immune response | 2.104712e-4 |
GO:0030511 | positive regulation of transforming growth factor beta receptor signaling pathway | 2.292219e-4 |
GO:0019323 | pentose catabolic process | 2.349637e-4 |
GO:0051066 | dihydrobiopterin metabolic process | 2.374504e-4 |
GO:0070861 | regulation of protein exit from endoplasmic reticulum | 2.384673e-4 |
GO:0060213 | positive regulation of nuclear-transcribed mRNA poly(A) tail shortening | 2.446747e-4 |
GO:2000119 | negative regulation of sodium-dependent phosphate transport | 2.524365e-4 |
GO:0044283 | small molecule biosynthetic process | 2.543535e-4 |
GO:0021905 | forebrain-midbrain boundary formation | 2.603078e-4 |
GO:0021918 | regulation of transcription from RNA polymerase II promoter involved in somatic motor neuron fate commitment | 2.603078e-4 |
GO:0021902 | commitment of neuronal cell to specific neuron type in forebrain | 2.603078e-4 |
GO:0003322 | pancreatic A cell development | 2.603078e-4 |
GO:0031274 | positive regulation of pseudopodium assembly | 2.652384e-4 |
GO:2000273 | positive regulation of receptor activity | 2.798680e-4 |
GO:0060048 | cardiac muscle contraction | 2.893447e-4 |
GO:0042278 | purine nucleoside metabolic process | 2.928167e-4 |
GO:0002885 | positive regulation of hypersensitivity | 2.975090e-4 |
GO:0002504 | antigen processing and presentation of peptide or polysaccharide antigen via MHC class II | 3.119409e-4 |
GO:0007187 | G-protein signaling, coupled to cyclic nucleotide second messenger | 3.221470e-4 |
GO:0006537 | glutamate biosynthetic process | 3.241495e-4 |
GO:0002904 | positive regulation of B cell apoptosis | 3.344584e-4 |
GO:0008634 | negative regulation of survival gene product expression | 3.347265e-4 |
GO:0042534 | regulation of tumor necrosis factor biosynthetic process | 3.348815e-4 |
GO:0031648 | protein destabilization | 3.536465e-4 |
GO:0042059 | negative regulation of epidermal growth factor receptor signaling pathway | 3.597328e-4 |
GO:0007191 | activation of adenylate cyclase activity by dopamine receptor signaling pathway | 3.660723e-4 |
GO:0042345 | regulation of NF-kappaB import into nucleus | 3.676439e-4 |
GO:0014894 | response to denervation involved in regulation of muscle adaptation | 3.756886e-4 |
GO:0051005 | negative regulation of lipoprotein lipase activity | 3.756886e-4 |
GO:0042137 | sequestering of neurotransmitter | 3.780626e-4 |
GO:0046128 | purine ribonucleoside metabolic process | 3.907095e-4 |
GO:0002920 | regulation of humoral immune response | 3.929819e-4 |
GO:0055015 | ventricular cardiac muscle cell development | 3.948557e-4 |
GO:0060491 | regulation of cell projection assembly | 3.962716e-4 |
GO:0044106 | cellular amine metabolic process | 4.099979e-4 |
GO:0006955 | immune response | 4.165167e-4 |
GO:0010765 | positive regulation of sodium ion transport | 4.177942e-4 |
GO:0050855 | regulation of B cell receptor signaling pathway | 4.257631e-4 |
GO:0007422 | peripheral nervous system development | 4.291105e-4 |
GO:0051169 | nuclear transport | 4.318418e-4 |
GO:2000060 | positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process | 4.480139e-4 |
GO:0014896 | muscle hypertrophy | 4.491649e-4 |
GO:0008652 | cellular amino acid biosynthetic process | 4.562246e-4 |
GO:0006690 | icosanoid metabolic process | 4.650847e-4 |
GO:0070543 | response to linoleic acid | 4.651173e-4 |
GO:0034696 | response to prostaglandin F stimulus | 4.651173e-4 |
GO:0019303 | D-ribose catabolic process | 4.651173e-4 |
GO:0010933 | positive regulation of macrophage tolerance induction | 4.651173e-4 |
GO:0060419 | heart growth | 4.695410e-4 |
GO:0019918 | peptidyl-arginine methylation, to symmetrical-dimethyl arginine | 4.925455e-4 |
GO:0006879 | cellular iron ion homeostasis | 5.016873e-4 |
GO:0001970 | positive regulation of activation of membrane attack complex | 5.230514e-4 |
GO:0090209 | negative regulation of triglyceride metabolic process | 5.243214e-4 |
GO:0035644 | phosphoanandamide dephosphorylation | 5.275178e-4 |
GO:0030449 | regulation of complement activation | 5.284797e-4 |
GO:0002016 | regulation of blood volume by renin-angiotensin | 5.458900e-4 |
GO:0030858 | positive regulation of epithelial cell differentiation | 5.485258e-4 |
GO:0006476 | protein deacetylation | 5.489299e-4 |
GO:0090035 | positive regulation of cellular chaperone-mediated protein complex assembly | 5.752668e-4 |
GO:0033559 | unsaturated fatty acid metabolic process | 5.812590e-4 |
GO:0071514 | genetic imprinting | 5.897029e-4 |
GO:2000107 | negative regulation of leukocyte apoptosis | 5.917180e-4 |
GO:0050685 | positive regulation of mRNA processing | 5.984143e-4 |
GO:0015807 | L-amino acid transport | 6.049797e-4 |
GO:0045087 | innate immune response | 6.117866e-4 |
GO:0060337 | type I interferon-mediated signaling pathway | 6.226174e-4 |
GO:0032020 | ISG15-protein conjugation | 6.272530e-4 |
GO:0034340 | response to type I interferon | 6.325732e-4 |
GO:0001999 | renal response to blood flow involved in circulatory renin-angiotensin regulation of systemic arterial blood pressure | 6.377617e-4 |
GO:0010758 | regulation of macrophage chemotaxis | 6.430206e-4 |
GO:0002902 | regulation of B cell apoptosis | 6.449162e-4 |
GO:0015893 | drug transport | 6.459145e-4 |
GO:0072197 | ureter morphogenesis | 7.008056e-4 |
GO:0030579 | ubiquitin-dependent SMAD protein catabolic process | 7.008056e-4 |
GO:0060742 | epithelial cell differentiation involved in prostate gland development | 7.044238e-4 |
GO:0030166 | proteoglycan biosynthetic process | 7.094195e-4 |
GO:0006805 | xenobiotic metabolic process | 7.352827e-4 |
GO:0042790 | transcription of nuclear large rRNA transcript from RNA polymerase I promoter | 7.355751e-4 |
GO:0030277 | maintenance of gastrointestinal epithelium | 7.421690e-4 |
GO:0010988 | regulation of low-density lipoprotein particle clearance | 7.736085e-4 |
GO:0051770 | positive regulation of nitric-oxide synthase biosynthetic process | 8.002319e-4 |
GO:0035262 | gonad morphogenesis | 8.187431e-4 |
GO:0010985 | negative regulation of lipoprotein particle clearance | 8.361573e-4 |
GO:0010916 | negative regulation of very-low-density lipoprotein particle clearance | 8.455108e-4 |
GO:0002407 | dendritic cell chemotaxis | 8.474261e-4 |
GO:0032455 | nerve growth factor processing | 8.517412e-4 |
GO:0055017 | cardiac muscle tissue growth | 8.544240e-4 |
GO:0006406 | mRNA export from nucleus | 8.683238e-4 |
GO:0043330 | response to exogenous dsRNA | 8.799235e-4 |
GO:0003015 | heart process | 8.808865e-4 |
GO:0009082 | branched chain family amino acid biosynthetic process | 8.965231e-4 |
GO:0035601 | protein deacylation | 8.971846e-4 |
GO:0060784 | regulation of cell proliferation involved in tissue homeostasis | 8.998392e-4 |
GO:2000138 | positive regulation of cell proliferation involved in heart morphogenesis | 8.998392e-4 |
GO:0003415 | chondrocyte hypertrophy | 8.998392e-4 |
GO:0060517 | epithelial cell proliferation involved in prostatic bud elongation | 8.998392e-4 |
GO:0035622 | intrahepatic bile duct development | 8.998392e-4 |
GO:0019100 | male germ-line sex determination | 8.998392e-4 |
GO:0014873 | response to muscle activity involved in regulation of muscle adaptation | 9.077844e-4 |
GO:0061049 | cell growth involved in cardiac muscle cell development | 9.077844e-4 |
GO:0002344 | B cell affinity maturation | 9.077844e-4 |
GO:0001998 | angiotensin mediated vasoconstriction involved in regulation of systemic arterial blood pressure | 9.077844e-4 |
GO:0003331 | positive regulation of extracellular matrix constituent secretion | 9.077844e-4 |
GO:0002478 | antigen processing and presentation of exogenous peptide antigen | 9.089174e-4 |
GO:0007169 | transmembrane receptor protein tyrosine kinase signaling pathway | 9.160618e-4 |
GO:0046724 | oxalic acid secretion | 9.314594e-4 |
GO:0019265 | glycine biosynthetic process, by transamination of glyoxylate | 9.314594e-4 |
GO:0090232 | positive regulation of spindle checkpoint | 9.362344e-4 |
GO:0045792 | negative regulation of cell size | 9.362344e-4 |
GO:0002883 | regulation of hypersensitivity | 9.441749e-4 |
GO:0042136 | neurotransmitter biosynthetic process | 9.488513e-4 |
GO:0042535 | positive regulation of tumor necrosis factor biosynthetic process | 9.534749e-4 |
GO:0045760 | positive regulation of action potential | 9.608992e-4 |
GO:0006607 | NLS-bearing substrate import into nucleus | 9.858057e-4 |
GO:0050747 | positive regulation of lipoprotein metabolic process | 1.001471e-3 |
GO:0070372 | regulation of ERK1 and ERK2 cascade | 1.005475e-3 |
GO:0044272 | sulfur compound biosynthetic process | 1.006405e-3 |
GO:0007263 | nitric oxide mediated signal transduction | 1.009104e-3 |
GO:0006555 | methionine metabolic process | 1.011090e-3 |
GO:0003044 | regulation of systemic arterial blood pressure mediated by a chemical signal | 1.022190e-3 |
GO:2000649 | regulation of sodium ion transmembrane transporter activity | 1.031723e-3 |
GO:0034776 | response to histamine | 1.038216e-3 |
GO:0001991 | regulation of systemic arterial blood pressure by circulatory renin-angiotensin | 1.104911e-3 |
GO:0035089 | establishment of apical/basal cell polarity | 1.121779e-3 |
GO:0014898 | cardiac muscle hypertrophy in response to stress | 1.138305e-3 |
GO:0046533 | negative regulation of photoreceptor cell differentiation | 1.149099e-3 |
GO:0042423 | catecholamine biosynthetic process | 1.209596e-3 |
GO:0071731 | response to nitric oxide | 1.219091e-3 |
GO:0006538 | glutamate catabolic process | 1.223509e-3 |
GO:0010759 | positive regulation of macrophage chemotaxis | 1.226905e-3 |
GO:0006285 | base-excision repair, AP site formation | 1.253384e-3 |
GO:0015074 | DNA integration | 1.257562e-3 |
GO:0060433 | bronchus development | 1.272516e-3 |
GO:0006952 | defense response | 1.309443e-3 |
GO:0007253 | cytoplasmic sequestering of NF-kappaB | 1.319136e-3 |
GO:0071459 | protein localization to chromosome, centromeric region | 1.329460e-3 |
GO:0002355 | detection of tumor cell | 1.329460e-3 |
GO:0030220 | platelet formation | 1.332627e-3 |
GO:0070374 | positive regulation of ERK1 and ERK2 cascade | 1.347648e-3 |
GO:0050884 | neuromuscular process controlling posture | 1.376088e-3 |
GO:0009065 | glutamine family amino acid catabolic process | 1.376323e-3 |
GO:0001580 | detection of chemical stimulus involved in sensory perception of bitter taste | 1.398697e-3 |
GO:0055025 | positive regulation of cardiac muscle tissue development | 1.401871e-3 |
GO:2000134 | negative regulation of G1/S transition of mitotic cell cycle | 1.432814e-3 |
GO:0071466 | cellular response to xenobiotic stimulus | 1.441682e-3 |
GO:0006621 | protein retention in ER lumen | 1.461875e-3 |
GO:0000387 | spliceosomal snRNP assembly | 1.514803e-3 |
GO:2001014 | regulation of skeletal muscle cell differentiation | 1.514803e-3 |
GO:0010832 | negative regulation of myotube differentiation | 1.515890e-3 |
GO:0042147 | retrograde transport, endosome to Golgi | 1.522957e-3 |
GO:0051403 | stress-activated MAPK cascade | 1.533856e-3 |
GO:0010882 | regulation of cardiac muscle contraction by calcium ion signaling | 1.534534e-3 |
GO:0018076 | N-terminal peptidyl-lysine acetylation | 1.541336e-3 |
GO:0003084 | positive regulation of systemic arterial blood pressure | 1.542272e-3 |
GO:0052565 | response to defense-related host nitric oxide production | 1.576625e-3 |
GO:0003051 | angiotensin-mediated drinking behavior | 1.576625e-3 |
GO:0043691 | reverse cholesterol transport | 1.585455e-3 |
GO:0015886 | heme transport | 1.657088e-3 |
GO:0007538 | primary sex determination | 1.678742e-3 |
GO:0043090 | amino acid import | 1.697529e-3 |
GO:0030823 | regulation of cGMP metabolic process | 1.706009e-3 |
GO:0021798 | forebrain dorsal/ventral pattern formation | 1.718644e-3 |
GO:0042053 | regulation of dopamine metabolic process | 1.737990e-3 |
GO:2000106 | regulation of leukocyte apoptosis | 1.759204e-3 |
GO:2000651 | positive regulation of sodium ion transmembrane transporter activity | 1.790850e-3 |
GO:0070145 | mitochondrial asparaginyl-tRNA aminoacylation | 1.799852e-3 |
GO:0090231 | regulation of spindle checkpoint | 1.816914e-3 |
GO:0010955 | negative regulation of protein processing | 1.831968e-3 |
GO:0033700 | phospholipid efflux | 1.850070e-3 |
GO:0060480 | lung goblet cell differentiation | 1.858038e-3 |
GO:0009435 | NAD biosynthetic process | 1.859722e-3 |
GO:0008050 | female courtship behavior | 1.870246e-3 |
GO:0032418 | lysosome localization | 1.889053e-3 |
GO:0035507 | regulation of myosin-light-chain-phosphatase activity | 1.938095e-3 |
GO:0006405 | RNA export from nucleus | 1.956681e-3 |
GO:0019883 | antigen processing and presentation of endogenous antigen | 1.966771e-3 |
GO:0009394 | 2'-deoxyribonucleotide metabolic process | 1.986029e-3 |
GO:0071622 | regulation of granulocyte chemotaxis | 2.026406e-3 |
GO:0035691 | macrophage migration inhibitory factor signaling pathway | 2.084977e-3 |
GO:0060528 | secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development | 2.129312e-3 |
GO:2000020 | positive regulation of male gonad development | 2.162009e-3 |
GO:0061384 | heart trabecular morphogenesis | 2.162009e-3 |
GO:0051225 | spindle assembly | 2.174712e-3 |
GO:0010613 | positive regulation of cardiac muscle hypertrophy | 2.195934e-3 |
GO:0060729 | intestinal epithelial structure maintenance | 2.208210e-3 |
GO:0033126 | positive regulation of GTP catabolic process | 2.208210e-3 |
GO:0045862 | positive regulation of proteolysis | 2.230638e-3 |
GO:0002739 | regulation of cytokine secretion involved in immune response | 2.260416e-3 |
GO:0051170 | nuclear import | 2.313538e-3 |
GO:0070947 | neutrophil mediated killing of fungus | 2.320615e-3 |
GO:0051388 | positive regulation of nerve growth factor receptor signaling pathway | 2.320615e-3 |
GO:0050710 | negative regulation of cytokine secretion | 2.362500e-3 |
GO:0006474 | N-terminal protein amino acid acetylation | 2.365872e-3 |
GO:0043502 | regulation of muscle adaptation | 2.451122e-3 |
GO:0033002 | muscle cell proliferation | 2.460702e-3 |
GO:0032914 | positive regulation of transforming growth factor beta1 production | 2.475476e-3 |
GO:0070914 | UV-damage excision repair | 2.486255e-3 |
GO:0002866 | positive regulation of acute inflammatory response to antigenic stimulus | 2.490288e-3 |
GO:0048311 | mitochondrion distribution | 2.502011e-3 |
GO:0008065 | establishment of blood-nerve barrier | 2.543077e-3 |
GO:0046456 | icosanoid biosynthetic process | 2.576931e-3 |
GO:0042069 | regulation of catecholamine metabolic process | 2.717155e-3 |
GO:0003073 | regulation of systemic arterial blood pressure | 2.734522e-3 |
GO:0002645 | positive regulation of tolerance induction | 2.791279e-3 |
GO:2000058 | regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process | 2.791279e-3 |
GO:0009410 | response to xenobiotic stimulus | 2.893583e-3 |
GO:0035166 | post-embryonic hemopoiesis | 2.991657e-3 |
GO:0021796 | cerebral cortex regionalization | 3.020213e-3 |
GO:0051088 | PMA-inducible membrane protein ectodomain proteolysis | 3.020213e-3 |
GO:0033148 | positive regulation of estrogen receptor signaling pathway | 3.056329e-3 |
GO:0031663 | lipopolysaccharide-mediated signaling pathway | 3.088675e-3 |
GO:0006769 | nicotinamide metabolic process | 3.094120e-3 |
GO:0046655 | folic acid metabolic process | 3.094120e-3 |
GO:0019511 | peptidyl-proline hydroxylation | 3.140281e-3 |
GO:0008588 | release of cytoplasmic sequestered NF-kappaB | 3.167378e-3 |
GO:0006636 | unsaturated fatty acid biosynthetic process | 3.183823e-3 |
GO:0008272 | sulfate transport | 3.194422e-3 |
GO:0006356 | regulation of transcription from RNA polymerase I promoter | 3.201504e-3 |
GO:0051769 | regulation of nitric-oxide synthase biosynthetic process | 3.207085e-3 |
GO:0060134 | prepulse inhibition | 3.252157e-3 |
GO:0006540 | glutamate decarboxylation to succinate | 3.341299e-3 |
GO:0097022 | lymphocyte migration into lymph node | 3.341299e-3 |
GO:0050713 | negative regulation of interleukin-1 beta secretion | 3.341299e-3 |
GO:0006509 | membrane protein ectodomain proteolysis | 3.343343e-3 |
GO:0010751 | negative regulation of nitric oxide mediated signal transduction | 3.389660e-3 |
GO:0043652 | engulfment of apoptotic cell | 3.389660e-3 |
GO:0010754 | negative regulation of cGMP-mediated signaling | 3.389660e-3 |
GO:0002605 | negative regulation of dendritic cell antigen processing and presentation | 3.389660e-3 |
GO:0002581 | negative regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II | 3.389660e-3 |
GO:0060047 | heart contraction | 3.420594e-3 |
GO:0006692 | prostanoid metabolic process | 3.457170e-3 |
GO:0031329 | regulation of cellular catabolic process | 3.461776e-3 |
GO:0002906 | negative regulation of mature B cell apoptosis | 3.470828e-3 |
GO:0051665 | membrane raft localization | 3.470828e-3 |
GO:0042537 | benzene-containing compound metabolic process | 3.477869e-3 |
GO:0070228 | regulation of lymphocyte apoptosis | 3.528746e-3 |
GO:0030802 | regulation of cyclic nucleotide biosynthetic process | 3.559567e-3 |
GO:0003061 | positive regulation of the force of heart contraction by norepinephrine | 3.596850e-3 |
GO:0061051 | positive regulation of cell growth involved in cardiac muscle cell development | 3.596850e-3 |
GO:0043249 | erythrocyte maturation | 3.597891e-3 |
GO:0050883 | musculoskeletal movement, spinal reflex action | 3.713406e-3 |
GO:0006571 | tyrosine biosynthetic process | 3.713406e-3 |
GO:0031161 | phosphatidylinositol catabolic process | 3.713406e-3 |
GO:0000462 | maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) | 3.719191e-3 |
GO:0032908 | regulation of transforming growth factor beta1 production | 3.726289e-3 |
GO:0034341 | response to interferon-gamma | 3.745193e-3 |
GO:0090307 | spindle assembly involved in mitosis | 3.814837e-3 |
GO:0030206 | chondroitin sulfate biosynthetic process | 3.814977e-3 |
GO:0007619 | courtship behavior | 3.832307e-3 |
GO:0014902 | myotube differentiation | 3.853653e-3 |
GO:0038027 | apolipoprotein A-I-mediated signaling pathway | 3.922585e-3 |
GO:0006520 | cellular amino acid metabolic process | 3.929324e-3 |
GO:2000018 | regulation of male gonad development | 3.929350e-3 |
GO:0002495 | antigen processing and presentation of peptide antigen via MHC class II | 3.973005e-3 |
GO:0021892 | cerebral cortex GABAergic interneuron differentiation | 4.035998e-3 |
GO:0072233 | metanephric thick ascending limb development | 4.038627e-3 |
GO:0072218 | metanephric ascending thin limb development | 4.038627e-3 |
GO:0001778 | plasma membrane repair | 4.041432e-3 |
GO:0060221 | retinal rod cell differentiation | 4.045813e-3 |
GO:0090031 | positive regulation of steroid hormone biosynthetic process | 4.052964e-3 |
GO:0006885 | regulation of pH | 4.055708e-3 |
GO:0040037 | negative regulation of fibroblast growth factor receptor signaling pathway | 4.069353e-3 |
GO:0050690 | regulation of defense response to virus by virus | 4.078358e-3 |
GO:0071675 | regulation of mononuclear cell migration | 4.139126e-3 |
GO:0048755 | branching morphogenesis of a nerve | 4.168887e-3 |
GO:0030162 | regulation of proteolysis | 4.214303e-3 |
GO:0002408 | myeloid dendritic cell chemotaxis | 4.349802e-3 |
GO:0072610 | interleukin-12 secretion | 4.349802e-3 |
GO:0035914 | skeletal muscle cell differentiation | 4.374782e-3 |
GO:0045986 | negative regulation of smooth muscle contraction | 4.377529e-3 |
GO:0060414 | aorta smooth muscle tissue morphogenesis | 4.384084e-3 |
GO:0006606 | protein import into nucleus | 4.398593e-3 |
GO:0006691 | leukotriene metabolic process | 4.414801e-3 |
GO:0060621 | negative regulation of cholesterol import | 4.420495e-3 |
GO:0071260 | cellular response to mechanical stimulus | 4.461539e-3 |
GO:0032463 | negative regulation of protein homooligomerization | 4.470323e-3 |
GO:0007173 | epidermal growth factor receptor signaling pathway | 4.499655e-3 |
GO:0035556 | intracellular signal transduction | 4.561875e-3 |
GO:0003139 | secondary heart field specification | 4.601003e-3 |
GO:0015031 | protein transport | 4.675522e-3 |
GO:0051043 | regulation of membrane protein ectodomain proteolysis | 4.684267e-3 |
GO:0019359 | nicotinamide nucleotide biosynthetic process | 4.723432e-3 |
GO:0006957 | complement activation, alternative pathway | 4.751146e-3 |
GO:0070229 | negative regulation of lymphocyte apoptosis | 4.784431e-3 |
GO:0006633 | fatty acid biosynthetic process | 4.838725e-3 |
GO:0010757 | negative regulation of plasminogen activation | 4.952049e-3 |
GO:0019886 | antigen processing and presentation of exogenous peptide antigen via MHC class II | 4.966324e-3 |
GO:0070498 | interleukin-1-mediated signaling pathway | 4.997829e-3 |
GO:0046960 | sensitization | 5.032183e-3 |
GO:0043148 | mitotic spindle stabilization | 5.032183e-3 |
GO:0010746 | regulation of plasma membrane long-chain fatty acid transport | 5.058514e-3 |
GO:0006090 | pyruvate metabolic process | 5.058514e-3 |
GO:0043092 | L-amino acid import | 5.082250e-3 |
GO:0030183 | B cell differentiation | 5.165891e-3 |
GO:0033601 | positive regulation of mammary gland epithelial cell proliferation | 5.177721e-3 |
GO:0010748 | negative regulation of plasma membrane long-chain fatty acid transport | 5.181118e-3 |
GO:0006576 | cellular biogenic amine metabolic process | 5.236152e-3 |
GO:0006865 | amino acid transport | 5.255913e-3 |
GO:0048711 | positive regulation of astrocyte differentiation | 5.297990e-3 |
GO:0002347 | response to tumor cell | 5.330840e-3 |
GO:0031331 | positive regulation of cellular catabolic process | 5.345158e-3 |
GO:0048144 | fibroblast proliferation | 5.430388e-3 |
GO:0030828 | positive regulation of cGMP biosynthetic process | 5.532394e-3 |
GO:0019370 | leukotriene biosynthetic process | 5.572921e-3 |
GO:0090023 | positive regulation of neutrophil chemotaxis | 5.729051e-3 |
GO:0006891 | intra-Golgi vesicle-mediated transport | 5.738826e-3 |
GO:0010934 | macrophage cytokine production | 5.848836e-3 |
GO:0009108 | coenzyme biosynthetic process | 5.864400e-3 |
GO:0002339 | B cell selection | 5.872849e-3 |
GO:0045906 | negative regulation of vasoconstriction | 5.873893e-3 |
GO:0010621 | negative regulation of transcription by transcription factor localization | 5.930391e-3 |
GO:0022011 | myelination in peripheral nervous system | 5.949655e-3 |
GO:0051489 | regulation of filopodium assembly | 6.024520e-3 |
GO:2000343 | positive regulation of chemokine (C-X-C motif) ligand 2 production | 6.032448e-3 |
GO:0018958 | phenol-containing compound metabolic process | 6.062806e-3 |
GO:0030502 | negative regulation of bone mineralization | 6.078575e-3 |
GO:0050886 | endocrine process | 6.108997e-3 |
GO:0042416 | dopamine biosynthetic process | 6.124349e-3 |
GO:0060314 | regulation of ryanodine-sensitive calcium-release channel activity | 6.158043e-3 |
GO:0060125 | negative regulation of growth hormone secretion | 6.230958e-3 |
GO:0051463 | negative regulation of cortisol secretion | 6.230958e-3 |
GO:0006867 | asparagine transport | 6.230958e-3 |
GO:0000088 | mitotic prophase | 6.230958e-3 |
GO:0051084 | 'de novo' posttranslational protein folding | 6.243908e-3 |
GO:0016575 | histone deacetylation | 6.255224e-3 |
GO:0045346 | regulation of MHC class II biosynthetic process | 6.306889e-3 |
GO:0045981 | positive regulation of nucleotide metabolic process | 6.357307e-3 |
GO:0002467 | germinal center formation | 6.363125e-3 |
GO:0048873 | homeostasis of number of cells within a tissue | 6.365549e-3 |
GO:0070417 | cellular response to cold | 6.521087e-3 |
GO:0009191 | ribonucleoside diphosphate catabolic process | 6.521087e-3 |
GO:0060347 | heart trabecula formation | 6.536839e-3 |
GO:0070863 | positive regulation of protein exit from endoplasmic reticulum | 6.541303e-3 |
GO:0007224 | smoothened signaling pathway | 6.578402e-3 |
GO:0006458 | 'de novo' protein folding | 6.578402e-3 |
GO:0042346 | positive regulation of NF-kappaB import into nucleus | 6.768315e-3 |
GO:0034653 | retinoic acid catabolic process | 6.781455e-3 |
GO:0006140 | regulation of nucleotide metabolic process | 6.791387e-3 |
GO:0032436 | positive regulation of proteasomal ubiquitin-dependent protein catabolic process | 6.866675e-3 |
GO:0007621 | negative regulation of female receptivity | 6.970164e-3 |
GO:0002067 | glandular epithelial cell differentiation | 7.020335e-3 |
GO:0009262 | deoxyribonucleotide metabolic process | 7.020781e-3 |
GO:0060333 | interferon-gamma-mediated signaling pathway | 7.032409e-3 |
GO:2000467 | positive regulation of glycogen (starch) synthase activity | 7.051213e-3 |
GO:0042417 | dopamine metabolic process | 7.121545e-3 |
GO:0007212 | dopamine receptor signaling pathway | 7.186324e-3 |
GO:0060164 | regulation of timing of neuron differentiation | 7.217038e-3 |
GO:0006433 | prolyl-tRNA aminoacylation | 7.263702e-3 |
GO:0035625 | epidermal growth factor-activated receptor transactivation by G-protein coupled receptor signaling pathway | 7.293264e-3 |
GO:0051987 | positive regulation of attachment of spindle microtubules to kinetochore | 7.295009e-3 |
GO:0046680 | response to DDT | 7.295009e-3 |
GO:0071283 | cellular response to iron(III) ion | 7.295009e-3 |
GO:0060623 | regulation of chromosome condensation | 7.295009e-3 |
GO:0001519 | peptide amidation | 7.295009e-3 |
GO:0007113 | endomitotic cell cycle | 7.295009e-3 |
GO:0031860 | telomeric 3' overhang formation | 7.295009e-3 |
GO:0043456 | regulation of pentose-phosphate shunt | 7.295009e-3 |
GO:0009264 | deoxyribonucleotide catabolic process | 7.362143e-3 |
GO:0010984 | regulation of lipoprotein particle clearance | 7.407361e-3 |
GO:0045347 | negative regulation of MHC class II biosynthetic process | 7.407361e-3 |
GO:0010874 | regulation of cholesterol efflux | 7.417270e-3 |
GO:0051016 | barbed-end actin filament capping | 7.478614e-3 |
GO:0045354 | regulation of interferon-alpha biosynthetic process | 7.522557e-3 |
GO:0002544 | chronic inflammatory response | 7.527325e-3 |
GO:0045924 | regulation of female receptivity | 7.649710e-3 |
GO:0002551 | mast cell chemotaxis | 7.730334e-3 |
GO:0045717 | negative regulation of fatty acid biosynthetic process | 7.785551e-3 |
GO:0009820 | alkaloid metabolic process | 8.106635e-3 |
GO:0050711 | negative regulation of interleukin-1 secretion | 8.125050e-3 |
GO:0060620 | regulation of cholesterol import | 8.125050e-3 |
GO:0040030 | regulation of molecular function, epigenetic | 8.131473e-3 |
GO:0048193 | Golgi vesicle transport | 8.212146e-3 |
GO:0060482 | lobar bronchus development | 8.259815e-3 |
GO:0000041 | transition metal ion transport | 8.260775e-3 |
GO:0072236 | metanephric loop of Henle development | 8.267931e-3 |
GO:0060292 | long term synaptic depression | 8.362755e-3 |
GO:0044070 | regulation of anion transport | 8.362755e-3 |
GO:0002864 | regulation of acute inflammatory response to antigenic stimulus | 8.362755e-3 |
GO:0031330 | negative regulation of cellular catabolic process | 8.381805e-3 |
GO:0032606 | type I interferon production | 8.386501e-3 |
GO:0014816 | satellite cell differentiation | 8.441217e-3 |
GO:0010954 | positive regulation of protein processing | 8.453054e-3 |
GO:2000725 | regulation of cardiac muscle cell differentiation | 8.468760e-3 |
GO:0032922 | circadian regulation of gene expression | 8.518698e-3 |
GO:0001798 | positive regulation of type IIa hypersensitivity | 8.518698e-3 |
GO:0070286 | axonemal dynein complex assembly | 8.622043e-3 |
GO:0007206 | activation of phospholipase C activity by metabotropic glutamate receptor signaling pathway | 8.622043e-3 |
GO:0033539 | fatty acid beta-oxidation using acyl-CoA dehydrogenase | 8.629584e-3 |
GO:0002440 | production of molecular mediator of immune response | 8.654661e-3 |
GO:0042058 | regulation of epidermal growth factor receptor signaling pathway | 8.672816e-3 |
GO:0006562 | proline catabolic process | 8.757764e-3 |
GO:0019060 | intracellular transport of viral proteins in host cell | 8.757764e-3 |
GO:0032414 | positive regulation of ion transmembrane transporter activity | 8.883110e-3 |
GO:0060678 | dichotomous subdivision of terminal units involved in ureteric bud branching | 9.032137e-3 |
GO:0002035 | brain renin-angiotensin system | 9.032137e-3 |
GO:0007521 | muscle cell fate determination | 9.053138e-3 |
GO:0055091 | phospholipid homeostasis | 9.146264e-3 |
GO:0046532 | regulation of photoreceptor cell differentiation | 9.183912e-3 |
GO:0006353 | transcription termination, DNA-dependent | 9.294474e-3 |
GO:0048011 | nerve growth factor receptor signaling pathway | 9.313481e-3 |
GO:0034380 | high-density lipoprotein particle assembly | 9.338240e-3 |
GO:0018200 | peptidyl-glutamic acid modification | 9.356467e-3 |
GO:0050953 | sensory perception of light stimulus | 9.478626e-3 |
GO:0015837 | amine transport | 9.502642e-3 |
GO:0008016 | regulation of heart contraction | 9.542752e-3 |
GO:0002224 | toll-like receptor signaling pathway | 9.664679e-3 |
GO:0043982 | histone H4-K8 acetylation | 9.667585e-3 |
GO:0043981 | histone H4-K5 acetylation | 9.667585e-3 |
GO:0060009 | Sertoli cell development | 9.859359e-3 |
GO:0034762 | regulation of transmembrane transport | 9.883561e-3 |
GO:0007617 | mating behavior | 9.895124e-3 |
GO:0019752 | carboxylic acid metabolic process | 9.951633e-3 |
GO:0034499 | late endosome to Golgi transport | 1.001236e-2 |
GO:0071955 | recycling endosome to Golgi transport | 1.001236e-2 |
GO:0021759 | globus pallidus development | 1.001236e-2 |
GO:0060304 | regulation of phosphatidylinositol dephosphorylation | 1.002905e-2 |
GO:0034241 | positive regulation of macrophage fusion | 1.002905e-2 |
GO:0051932 | synaptic transmission, GABAergic | 1.002905e-2 |
GO:0042424 | catecholamine catabolic process | 1.006202e-2 |
GO:0032506 | cytokinetic process | 1.009594e-2 |
GO:0015872 | dopamine transport | 1.022548e-2 |
GO:0070849 | response to epidermal growth factor stimulus | 1.026124e-2 |
GO:0070168 | negative regulation of biomineral tissue development | 1.030836e-2 |
GO:0032787 | monocarboxylic acid metabolic process | 1.034388e-2 |
GO:0032376 | positive regulation of cholesterol transport | 1.037813e-2 |
GO:0033145 | positive regulation of steroid hormone receptor signaling pathway | 1.037874e-2 |
GO:0090100 | positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway | 1.037954e-2 |
GO:0042347 | negative regulation of NF-kappaB import into nucleus | 1.042665e-2 |
GO:0046968 | peptide antigen transport | 1.044395e-2 |
GO:0061036 | positive regulation of cartilage development | 1.048418e-2 |
GREAT analysis results for mouseGenomic Enrichment of Annotations Tool (GREAT, Nat Biotechnol. 2010 May;28(5):495-501) is used to identify, both in human and in mouse, the gene ontology terms of biological processes enriched given the predicted TFBSs, and evaluated the overlap in the top-500 gene ontology terms between human and mouse. For each novel motif, the P value for the overlap was then evaluated by calculating its relative rank with respect to this background distribution.<br>Analyst: Michiel de Hoon <br><br>link to source dataset <br>data
GO ID | GO Term | p-value |
---|---|---|
GO:0072166 | posterior mesonephric tubule development | 5.859992e-13 |
GO:0072302 | negative regulation of metanephric glomerular mesangial cell proliferation | 3.303653e-11 |
GO:2001076 | positive regulation of metanephric ureteric bud development | 3.303653e-11 |
GO:0007356 | thorax and anterior abdomen determination | 3.303653e-11 |
GO:0043503 | skeletal muscle fiber adaptation | 2.180020e-10 |
GO:0072125 | negative regulation of glomerular mesangial cell proliferation | 8.795001e-9 |
GO:0046498 | S-adenosylhomocysteine metabolic process | 1.919179e-8 |
GO:0051725 | protein de-ADP-ribosylation | 2.461955e-8 |
GO:0072301 | regulation of metanephric glomerular mesangial cell proliferation | 2.977747e-8 |
GO:0072015 | glomerular visceral epithelial cell development | 4.007521e-8 |
GO:0072124 | regulation of glomerular mesangial cell proliferation | 7.749351e-8 |
GO:0035802 | adrenal cortex formation | 9.013114e-8 |
GO:0032218 | riboflavin transport | 1.372684e-7 |
GO:0043501 | skeletal muscle adaptation | 8.462233e-7 |
GO:0034441 | plasma lipoprotein particle oxidation | 9.116048e-7 |
GO:0072284 | metanephric S-shaped body morphogenesis | 2.183425e-6 |
GO:0072278 | metanephric comma-shaped body morphogenesis | 2.183425e-6 |
GO:0051180 | vitamin transport | 2.477025e-6 |
GO:0045926 | negative regulation of growth | 3.146159e-6 |
GO:0021794 | thalamus development | 3.860643e-6 |
GO:0051973 | positive regulation of telomerase activity | 4.015767e-6 |
GO:0072298 | regulation of metanephric glomerulus development | 4.103761e-6 |
GO:0090192 | regulation of glomerulus development | 4.692545e-6 |
GO:0030308 | negative regulation of cell growth | 4.843369e-6 |
GO:0060539 | diaphragm development | 5.175314e-6 |
GO:0050427 | 3'-phosphoadenosine 5'-phosphosulfate metabolic process | 6.176175e-6 |
GO:0070483 | detection of hypoxia | 6.348771e-6 |
GO:0001920 | negative regulation of receptor recycling | 6.348771e-6 |
GO:0090082 | positive regulation of heart induction by negative regulation of canonical Wnt receptor signaling pathway | 7.692007e-6 |
GO:0003032 | detection of oxygen | 7.735625e-6 |
GO:0060923 | cardiac muscle cell fate commitment | 8.378053e-6 |
GO:0048013 | ephrin receptor signaling pathway | 8.996166e-6 |
GO:0051403 | stress-activated MAPK cascade | 9.486602e-6 |
GO:0009119 | ribonucleoside metabolic process | 1.129921e-5 |
GO:0072215 | regulation of metanephros development | 1.393670e-5 |
GO:0071320 | cellular response to cAMP | 1.405617e-5 |
GO:0060911 | cardiac cell fate commitment | 1.466342e-5 |
GO:0046653 | tetrahydrofolate metabolic process | 1.541494e-5 |
GO:0007621 | negative regulation of female receptivity | 1.809584e-5 |
GO:0044246 | regulation of multicellular organismal metabolic process | 1.811635e-5 |
GO:0032728 | positive regulation of interferon-beta production | 1.916709e-5 |
GO:0044253 | positive regulation of multicellular organismal metabolic process | 2.175488e-5 |
GO:0006575 | cellular modified amino acid metabolic process | 2.728490e-5 |
GO:0060561 | apoptosis involved in morphogenesis | 3.280994e-5 |
GO:0032648 | regulation of interferon-beta production | 3.546252e-5 |
GO:0007354 | zygotic determination of anterior/posterior axis, embryo | 3.943220e-5 |
GO:0046395 | carboxylic acid catabolic process | 3.963398e-5 |
GO:0050999 | regulation of nitric-oxide synthase activity | 4.275358e-5 |
GO:2000194 | regulation of female gonad development | 4.931403e-5 |
GO:0032965 | regulation of collagen biosynthetic process | 5.357454e-5 |
GO:0002355 | detection of tumor cell | 5.561707e-5 |
GO:0009062 | fatty acid catabolic process | 5.616818e-5 |
GO:2000195 | negative regulation of female gonad development | 6.127264e-5 |
GO:0032967 | positive regulation of collagen biosynthetic process | 6.268092e-5 |
GO:0007172 | signal complex assembly | 6.964326e-5 |
GO:0072112 | glomerular visceral epithelial cell differentiation | 7.517665e-5 |
GO:0002021 | response to dietary excess | 7.658274e-5 |
GO:0016191 | synaptic vesicle uncoating | 8.027051e-5 |
GO:0090026 | positive regulation of monocyte chemotaxis | 8.787590e-5 |
GO:0001300 | chronological cell aging | 8.872731e-5 |
GO:0042219 | cellular modified amino acid catabolic process | 9.743210e-5 |
GO:0042447 | hormone catabolic process | 9.908596e-5 |
GO:0046850 | regulation of bone remodeling | 9.987508e-5 |
GO:0046452 | dihydrofolate metabolic process | 1.212090e-4 |
GO:0071105 | response to interleukin-11 | 1.212090e-4 |
GO:0043500 | muscle adaptation | 1.248413e-4 |
GO:0072098 | anterior/posterior pattern specification involved in kidney development | 1.309001e-4 |
GO:0006398 | histone mRNA 3'-end processing | 1.309001e-4 |
GO:0048389 | intermediate mesoderm development | 1.309001e-4 |
GO:0003241 | growth involved in heart morphogenesis | 1.425905e-4 |
GO:0040008 | regulation of growth | 1.447952e-4 |
GO:0046500 | S-adenosylmethionine metabolic process | 1.492426e-4 |
GO:0021860 | pyramidal neuron development | 1.555240e-4 |
GO:0003308 | negative regulation of Wnt receptor signaling pathway involved in heart development | 1.562510e-4 |
GO:0060973 | cell migration involved in heart development | 1.611205e-4 |
GO:0045124 | regulation of bone resorption | 1.631098e-4 |
GO:0045082 | positive regulation of interleukin-10 biosynthetic process | 1.689725e-4 |
GO:0070278 | extracellular matrix constituent secretion | 1.712119e-4 |
GO:0010260 | organ senescence | 1.712119e-4 |
GO:0035644 | phosphoanandamide dephosphorylation | 1.714640e-4 |
GO:0070670 | response to interleukin-4 | 1.848100e-4 |
GO:0001558 | regulation of cell growth | 1.903246e-4 |
GO:0014888 | striated muscle adaptation | 1.951546e-4 |
GO:0009116 | nucleoside metabolic process | 1.952918e-4 |
GO:0060231 | mesenchymal to epithelial transition | 2.036223e-4 |
GO:0030853 | negative regulation of granulocyte differentiation | 2.069385e-4 |
GO:0008050 | female courtship behavior | 2.133087e-4 |
GO:0003214 | cardiac left ventricle morphogenesis | 2.172482e-4 |
GO:0034446 | substrate adhesion-dependent cell spreading | 2.196326e-4 |
GO:0050428 | 3'-phosphoadenosine 5'-phosphosulfate biosynthetic process | 2.240219e-4 |
GO:2000191 | regulation of fatty acid transport | 2.362132e-4 |
GO:0014028 | notochord formation | 2.476727e-4 |
GO:0002380 | immunoglobulin secretion involved in immune response | 2.476727e-4 |
GO:0003273 | cell migration involved in endocardial cushion formation | 2.476727e-4 |
GO:0072050 | S-shaped body morphogenesis | 2.708259e-4 |
GO:0072049 | comma-shaped body morphogenesis | 2.708259e-4 |
GO:0000288 | nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay | 2.863491e-4 |
GO:0032481 | positive regulation of type I interferon production | 3.062017e-4 |
GO:0000238 | zygotene | 3.169547e-4 |
GO:0046092 | deoxycytidine metabolic process | 3.181665e-4 |
GO:0061034 | olfactory bulb mitral cell layer development | 3.352471e-4 |
GO:0021884 | forebrain neuron development | 3.497272e-4 |
GO:0043366 | beta selection | 3.596260e-4 |
GO:0061005 | cell differentiation involved in kidney development | 3.624800e-4 |
GO:0090381 | regulation of heart induction | 3.815396e-4 |
GO:0015884 | folic acid transport | 3.839348e-4 |
GO:0022617 | extracellular matrix disassembly | 3.839348e-4 |
GO:0072355 | histone H3-T3 phosphorylation | 4.124965e-4 |
GO:0016042 | lipid catabolic process | 4.156816e-4 |
GO:0048741 | skeletal muscle fiber development | 4.171819e-4 |
GO:0001823 | mesonephros development | 4.250515e-4 |
GO:0009218 | pyrimidine ribonucleotide metabolic process | 4.916029e-4 |
GO:0042088 | T-helper 1 type immune response | 5.010881e-4 |
GO:0060421 | positive regulation of heart growth | 5.033595e-4 |
GO:0034103 | regulation of tissue remodeling | 5.101421e-4 |
GO:0090183 | regulation of kidney development | 5.163480e-4 |
GO:0072074 | kidney mesenchyme development | 5.342725e-4 |
GO:0060452 | positive regulation of cardiac muscle contraction | 5.424661e-4 |
GO:0070305 | response to cGMP | 5.507930e-4 |
GO:0021796 | cerebral cortex regionalization | 5.507930e-4 |
GO:0021542 | dentate gyrus development | 5.558739e-4 |
GO:2000018 | regulation of male gonad development | 6.086859e-4 |
GO:0072329 | monocarboxylic acid catabolic process | 6.209037e-4 |
GO:0072428 | signal transduction involved in intra-S DNA damage checkpoint | 6.274484e-4 |
GO:0016078 | tRNA catabolic process | 6.274484e-4 |
GO:0001682 | tRNA 5'-leader removal | 6.274484e-4 |
GO:0010310 | regulation of hydrogen peroxide metabolic process | 6.387813e-4 |
GO:0051591 | response to cAMP | 6.476582e-4 |
GO:0016082 | synaptic vesicle priming | 6.586800e-4 |
GO:0061032 | visceral serous pericardium development | 6.597926e-4 |
GO:0006213 | pyrimidine nucleoside metabolic process | 7.447079e-4 |
GO:0090185 | negative regulation of kidney development | 7.797042e-4 |
GO:0046128 | purine ribonucleoside metabolic process | 7.851994e-4 |
GO:0045089 | positive regulation of innate immune response | 8.138201e-4 |
GO:0045851 | pH reduction | 8.517679e-4 |
GO:0072190 | ureter urothelium development | 8.717997e-4 |
GO:0031427 | response to methotrexate | 8.880306e-4 |
GO:0030258 | lipid modification | 9.045883e-4 |
GO:0072164 | mesonephric tubule development | 9.279814e-4 |
GO:2000378 | negative regulation of reactive oxygen species metabolic process | 1.017315e-3 |
GO:0001937 | negative regulation of endothelial cell proliferation | 1.026474e-3 |
GO:0034059 | response to anoxia | 1.035074e-3 |
GO:0002220 | innate immune response activating cell surface receptor signaling pathway | 1.035074e-3 |
GO:0071247 | cellular response to chromate | 1.064028e-3 |
GO:2000020 | positive regulation of male gonad development | 1.119653e-3 |
GO:0035850 | epithelial cell differentiation involved in kidney development | 1.165676e-3 |
GO:0032479 | regulation of type I interferon production | 1.196414e-3 |
GO:0045601 | regulation of endothelial cell differentiation | 1.196414e-3 |
GO:0021935 | cerebellar granule cell precursor tangential migration | 1.201421e-3 |
GO:0006713 | glucocorticoid catabolic process | 1.201421e-3 |
GO:0006408 | snRNA export from nucleus | 1.201421e-3 |
GO:0046033 | AMP metabolic process | 1.219201e-3 |
GO:0032757 | positive regulation of interleukin-8 production | 1.243201e-3 |
GO:0007021 | tubulin complex assembly | 1.264454e-3 |
GO:0002043 | blood vessel endothelial cell proliferation involved in sprouting angiogenesis | 1.289282e-3 |
GO:0032753 | positive regulation of interleukin-4 production | 1.290055e-3 |
GO:0042404 | thyroid hormone catabolic process | 1.322972e-3 |
GO:0000578 | embryonic axis specification | 1.325005e-3 |
GO:0001881 | receptor recycling | 1.381130e-3 |
GO:0007618 | mating | 1.381176e-3 |
GO:2000377 | regulation of reactive oxygen species metabolic process | 1.434521e-3 |
GO:0051293 | establishment of spindle localization | 1.436205e-3 |
GO:0046851 | negative regulation of bone remodeling | 1.458320e-3 |
GO:0006760 | folic acid-containing compound metabolic process | 1.469579e-3 |
GO:0035993 | deltoid tuberosity development | 1.481683e-3 |
GO:0061072 | iris morphogenesis | 1.514212e-3 |
GO:0051387 | negative regulation of nerve growth factor receptor signaling pathway | 1.570167e-3 |
GO:0060213 | positive regulation of nuclear-transcribed mRNA poly(A) tail shortening | 1.570167e-3 |
GO:0034612 | response to tumor necrosis factor | 1.588856e-3 |
GO:0010746 | regulation of plasma membrane long-chain fatty acid transport | 1.594846e-3 |
GO:0021535 | cell migration in hindbrain | 1.645861e-3 |
GO:0007525 | somatic muscle development | 1.667015e-3 |
GO:0071674 | mononuclear cell migration | 1.680291e-3 |
GO:0034498 | early endosome to Golgi transport | 1.680291e-3 |
GO:0002432 | granuloma formation | 1.680291e-3 |
GO:0031529 | ruffle organization | 1.751411e-3 |
GO:0051001 | negative regulation of nitric-oxide synthase activity | 1.759779e-3 |
GO:0007619 | courtship behavior | 1.759779e-3 |
GO:0000132 | establishment of mitotic spindle orientation | 1.806067e-3 |
GO:0072194 | kidney smooth muscle tissue development | 1.829298e-3 |
GO:0072273 | metanephric nephron morphogenesis | 1.869334e-3 |
GO:0090212 | negative regulation of establishment of blood-brain barrier | 1.896057e-3 |
GO:0015939 | pantothenate metabolic process | 1.896057e-3 |
GO:0051790 | short-chain fatty acid biosynthetic process | 1.896057e-3 |
GO:0050830 | defense response to Gram-positive bacterium | 1.920653e-3 |
GO:0021954 | central nervous system neuron development | 1.922406e-3 |
GO:0033057 | multicellular organismal reproductive behavior | 1.937037e-3 |
GO:0046125 | pyrimidine deoxyribonucleoside metabolic process | 1.941035e-3 |
GO:0032645 | regulation of granulocyte macrophage colony-stimulating factor production | 1.972021e-3 |
GO:0072668 | tubulin complex biogenesis | 2.035303e-3 |
GO:0090231 | regulation of spindle checkpoint | 2.069075e-3 |
GO:0032069 | regulation of nuclease activity | 2.069075e-3 |
GO:0045046 | protein import into peroxisome membrane | 2.085122e-3 |
GO:0010748 | negative regulation of plasma membrane long-chain fatty acid transport | 2.139307e-3 |
GO:0051099 | positive regulation of binding | 2.167309e-3 |
GO:0032863 | activation of Rac GTPase activity | 2.257552e-3 |
GO:0072208 | metanephric smooth muscle tissue development | 2.288560e-3 |
GO:0090094 | metanephric cap mesenchymal cell proliferation involved in metanephros development | 2.288560e-3 |
GO:0072259 | metanephric interstitial cell development | 2.288560e-3 |
GO:0072168 | specification of anterior mesonephric tubule identity | 2.288560e-3 |
GO:0072169 | specification of posterior mesonephric tubule identity | 2.288560e-3 |
GO:0072184 | renal vesicle progenitor cell differentiation | 2.288560e-3 |
GO:0034374 | low-density lipoprotein particle remodeling | 2.333036e-3 |
GO:0045602 | negative regulation of endothelial cell differentiation | 2.367505e-3 |
GO:0050680 | negative regulation of epithelial cell proliferation | 2.488913e-3 |
GO:0009220 | pyrimidine ribonucleotide biosynthetic process | 2.526781e-3 |
GO:0001732 | formation of translation initiation complex | 2.541557e-3 |
GO:0006540 | glutamate decarboxylation to succinate | 2.611239e-3 |
GO:0046499 | S-adenosylmethioninamine metabolic process | 2.627275e-3 |
GO:0032817 | regulation of natural killer cell proliferation | 2.752925e-3 |
GO:0045768 | positive regulation of anti-apoptosis | 2.775839e-3 |
GO:0031122 | cytoplasmic microtubule organization | 2.804062e-3 |
GO:0061098 | positive regulation of protein tyrosine kinase activity | 2.855118e-3 |
GO:0046131 | pyrimidine ribonucleoside metabolic process | 2.868461e-3 |
GO:0031440 | regulation of mRNA 3'-end processing | 2.932142e-3 |
GO:0003382 | epithelial cell morphogenesis | 3.023803e-3 |
GO:0071872 | cellular response to epinephrine stimulus | 3.051236e-3 |
GO:0071548 | response to dexamethasone stimulus | 3.079040e-3 |
GO:0044242 | cellular lipid catabolic process | 3.090574e-3 |
GO:0003338 | metanephros morphogenesis | 3.121530e-3 |
GO:0032673 | regulation of interleukin-4 production | 3.121530e-3 |
GO:0034104 | negative regulation of tissue remodeling | 3.151897e-3 |
GO:0046833 | positive regulation of RNA export from nucleus | 3.195063e-3 |
GO:0008298 | intracellular mRNA localization | 3.211795e-3 |
GO:0021539 | subthalamus development | 3.211795e-3 |
GO:0060180 | female mating behavior | 3.214022e-3 |
GO:0034435 | cholesterol esterification | 3.214993e-3 |
GO:0001561 | fatty acid alpha-oxidation | 3.233008e-3 |
GO:0021905 | forebrain-midbrain boundary formation | 3.324812e-3 |
GO:0050975 | sensory perception of touch | 3.324812e-3 |
GO:0044205 | 'de novo' UMP biosynthetic process | 3.324812e-3 |
GO:0021918 | regulation of transcription from RNA polymerase II promoter involved in somatic motor neuron fate commitment | 3.324812e-3 |
GO:0021902 | commitment of neuronal cell to specific neuron type in forebrain | 3.324812e-3 |
GO:0003322 | pancreatic A cell development | 3.324812e-3 |
GO:0002865 | negative regulation of acute inflammatory response to antigenic stimulus | 3.324812e-3 |
GO:0006603 | phosphocreatine metabolic process | 3.324812e-3 |
GO:0040001 | establishment of mitotic spindle localization | 3.354454e-3 |
GO:0048199 | vesicle targeting, to, from or within Golgi | 3.364798e-3 |
GO:0043388 | positive regulation of DNA binding | 3.414036e-3 |
GO:0033865 | nucleoside bisphosphate metabolic process | 3.461938e-3 |
GO:0007617 | mating behavior | 3.461938e-3 |
GO:2000050 | regulation of non-canonical Wnt receptor signaling pathway | 3.496759e-3 |
GO:0021912 | regulation of transcription from RNA polymerase II promoter involved in spinal cord motor neuron fate specification | 3.499606e-3 |
GO:0035556 | intracellular signal transduction | 3.632592e-3 |
GO:0009063 | cellular amino acid catabolic process | 3.752746e-3 |
GO:0033124 | regulation of GTP catabolic process | 3.791710e-3 |
GO:0032741 | positive regulation of interleukin-18 production | 3.834064e-3 |
GO:0008208 | C21-steroid hormone catabolic process | 3.834064e-3 |
GO:0030858 | positive regulation of epithelial cell differentiation | 3.838237e-3 |
GO:0046856 | phosphatidylinositol dephosphorylation | 3.851915e-3 |
GO:0072075 | metanephric mesenchyme development | 3.871693e-3 |
GO:0021549 | cerebellum development | 3.906625e-3 |
GO:0043087 | regulation of GTPase activity | 3.954604e-3 |
GO:0015893 | drug transport | 4.008763e-3 |
GO:0051649 | establishment of localization in cell | 4.043036e-3 |
GO:0030852 | regulation of granulocyte differentiation | 4.103070e-3 |
GO:0001867 | complement activation, lectin pathway | 4.184501e-3 |
GO:0003417 | growth plate cartilage development | 4.291469e-3 |
GO:0030865 | cortical cytoskeleton organization | 4.298079e-3 |
GO:0042147 | retrograde transport, endosome to Golgi | 4.333865e-3 |
GO:2000753 | positive regulation of glucosylceramide catabolic process | 4.334308e-3 |
GO:2000755 | positive regulation of sphingomyelin catabolic process | 4.334308e-3 |
GO:0034154 | toll-like receptor 7 signaling pathway | 4.334308e-3 |
GO:0032185 | septin cytoskeleton organization | 4.334308e-3 |
GO:0000053 | argininosuccinate metabolic process | 4.334308e-3 |
GO:0010966 | regulation of phosphate transport | 4.334308e-3 |
GO:0043415 | positive regulation of skeletal muscle tissue regeneration | 4.342477e-3 |
GO:0048790 | maintenance of presynaptic active zone structure | 4.368657e-3 |
GO:0006844 | acyl carnitine transport | 4.368657e-3 |
GO:0015761 | mannose transport | 4.368657e-3 |
GO:0048015 | phosphatidylinositol-mediated signaling | 4.373239e-3 |
GO:0042278 | purine nucleoside metabolic process | 4.388826e-3 |
GO:0032677 | regulation of interleukin-8 production | 4.391959e-3 |
GO:0035434 | copper ion transmembrane transport | 4.433422e-3 |
GO:0019098 | reproductive behavior | 4.440802e-3 |
GO:0032075 | positive regulation of nuclease activity | 4.467929e-3 |
GO:0043048 | dolichyl monophosphate biosynthetic process | 4.468665e-3 |
GO:0035522 | monoubiquitinated histone H2A deubiquitination | 4.468665e-3 |
GO:0032680 | regulation of tumor necrosis factor production | 4.476112e-3 |
GO:0042662 | negative regulation of mesodermal cell fate specification | 4.568746e-3 |
GO:0045924 | regulation of female receptivity | 4.586855e-3 |
GO:0045779 | negative regulation of bone resorption | 4.592016e-3 |
GO:0072141 | renal interstitial cell development | 4.592648e-3 |
GO:0032319 | regulation of Rho GTPase activity | 4.631696e-3 |
GO:0043117 | positive regulation of vascular permeability | 4.637661e-3 |
GO:0010288 | response to lead ion | 4.659207e-3 |
GO:0044282 | small molecule catabolic process | 4.661044e-3 |
GO:0006528 | asparagine metabolic process | 4.764007e-3 |
GO:0032878 | regulation of establishment or maintenance of cell polarity | 4.948636e-3 |
GO:0005981 | regulation of glycogen catabolic process | 4.948636e-3 |
GO:2000304 | positive regulation of ceramide biosynthetic process | 4.953172e-3 |
GO:0006011 | UDP-glucose metabolic process | 4.953172e-3 |
GO:0051000 | positive regulation of nitric-oxide synthase activity | 5.037382e-3 |
GO:0010463 | mesenchymal cell proliferation | 5.039803e-3 |
GO:0015074 | DNA integration | 5.110231e-3 |
GO:0033628 | regulation of cell adhesion mediated by integrin | 5.193023e-3 |
GO:0045650 | negative regulation of macrophage differentiation | 5.411000e-3 |
GO:0016090 | prenol metabolic process | 5.413956e-3 |
GO:0031442 | positive regulation of mRNA 3'-end processing | 5.446328e-3 |
GO:0046600 | negative regulation of centriole replication | 5.656220e-3 |
GO:0006685 | sphingomyelin catabolic process | 5.656220e-3 |
GO:0045357 | regulation of interferon-beta biosynthetic process | 5.701612e-3 |
GO:0032855 | positive regulation of Rac GTPase activity | 5.747531e-3 |
GO:0051851 | modification by host of symbiont morphology or physiology | 5.794708e-3 |
GO:0046939 | nucleotide phosphorylation | 5.844492e-3 |
GO:0042136 | neurotransmitter biosynthetic process | 5.854917e-3 |
GO:0043491 | protein kinase B signaling cascade | 5.917123e-3 |
GO:0023021 | termination of signal transduction | 5.943979e-3 |
GO:0045780 | positive regulation of bone resorption | 6.022369e-3 |
GO:0045899 | positive regulation of RNA polymerase II transcriptional preinitiation complex assembly | 6.108547e-3 |
GO:0015705 | iodide transport | 6.154743e-3 |
GO:0042694 | muscle cell fate specification | 6.154743e-3 |
GO:0071321 | cellular response to cGMP | 6.154743e-3 |
GO:0035095 | behavioral response to nicotine | 6.154743e-3 |
GO:0030421 | defecation | 6.174081e-3 |
GO:0009107 | lipoate biosynthetic process | 6.174081e-3 |
GO:0010822 | positive regulation of mitochondrion organization | 6.233108e-3 |
GO:0051452 | intracellular pH reduction | 6.305266e-3 |
GO:0010771 | negative regulation of cell morphogenesis involved in differentiation | 6.305266e-3 |
GO:0045368 | positive regulation of interleukin-13 biosynthetic process | 6.306170e-3 |
GO:0051497 | negative regulation of stress fiber assembly | 6.427610e-3 |
GO:0006222 | UMP biosynthetic process | 6.427610e-3 |
GO:0051972 | regulation of telomerase activity | 6.564583e-3 |
GO:0009798 | axis specification | 6.590654e-3 |
GO:0006071 | glycerol metabolic process | 6.997125e-3 |
GO:0032091 | negative regulation of protein binding | 7.041432e-3 |
GO:0019439 | aromatic compound catabolic process | 7.090910e-3 |
GO:0061004 | pattern specification involved in kidney development | 7.183470e-3 |
GO:0046599 | regulation of centriole replication | 7.194129e-3 |
GO:0010755 | regulation of plasminogen activation | 7.217407e-3 |
GO:0048305 | immunoglobulin secretion | 7.223841e-3 |
GO:0001892 | embryonic placenta development | 7.268681e-3 |
GO:0032318 | regulation of Ras GTPase activity | 7.281398e-3 |
GO:0036006 | cellular response to macrophage colony-stimulating factor stimulus | 7.333449e-3 |
GO:0002575 | basophil chemotaxis | 7.333449e-3 |
GO:0035990 | tendon cell differentiation | 7.333449e-3 |
GO:0019400 | alditol metabolic process | 7.419383e-3 |
GO:0045638 | negative regulation of myeloid cell differentiation | 7.477062e-3 |
GO:0002762 | negative regulation of myeloid leukocyte differentiation | 7.516345e-3 |
GO:0060993 | kidney morphogenesis | 7.599611e-3 |
GO:0050778 | positive regulation of immune response | 7.846881e-3 |
GO:0032717 | negative regulation of interleukin-8 production | 7.924863e-3 |
GO:0032202 | telomere assembly | 7.951926e-3 |
GO:0008595 | anterior/posterior axis specification, embryo | 8.004883e-3 |
GO:0030240 | skeletal muscle thin filament assembly | 8.009323e-3 |
GO:2000679 | positive regulation of transcription regulatory region DNA binding | 8.034312e-3 |
GO:0006855 | drug transmembrane transport | 8.034312e-3 |
GO:0006887 | exocytosis | 8.087977e-3 |
GO:0072028 | nephron morphogenesis | 8.127289e-3 |
GO:0006987 | activation of signaling protein activity involved in unfolded protein response | 8.141996e-3 |
GO:0046504 | glycerol ether biosynthetic process | 8.154054e-3 |
GO:0002034 | regulation of blood vessel size by renin-angiotensin | 8.180934e-3 |
GO:0009161 | ribonucleoside monophosphate metabolic process | 8.236944e-3 |
GO:0032656 | regulation of interleukin-13 production | 8.306141e-3 |
GO:0034276 | kynurenic acid biosynthetic process | 8.330291e-3 |
GO:0035481 | positive regulation of Notch signaling pathway involved in heart induction | 8.330291e-3 |
GO:0060975 | cardioblast migration to the midline involved in heart field formation | 8.330291e-3 |
GO:0006517 | protein deglycosylation | 8.330291e-3 |
GO:0040010 | positive regulation of growth rate | 8.330291e-3 |
GO:0003259 | cardioblast anterior-lateral migration | 8.330291e-3 |
GO:0002534 | cytokine production involved in inflammatory response | 8.330291e-3 |
GO:0003243 | circumferential growth involved in left ventricle morphogenesis | 8.330291e-3 |
GO:0003210 | cardiac atrium formation | 8.330291e-3 |
GO:0003236 | sinus venosus morphogenesis | 8.330291e-3 |
GO:0070926 | regulation of ATP:ADP antiporter activity | 8.499443e-3 |
GO:0042407 | cristae formation | 8.499443e-3 |
GO:0032835 | glomerulus development | 8.580333e-3 |
GO:0010159 | specification of organ position | 8.600638e-3 |
GO:0010757 | negative regulation of plasminogen activation | 8.643039e-3 |
GO:0030194 | positive regulation of blood coagulation | 8.713144e-3 |
GO:0046839 | phospholipid dephosphorylation | 8.938174e-3 |
GO:0043687 | post-translational protein modification | 9.249754e-3 |
GO:0021978 | telencephalon regionalization | 9.249754e-3 |
GO:2000052 | positive regulation of non-canonical Wnt receptor signaling pathway | 9.426254e-3 |
GO:0051549 | positive regulation of keratinocyte migration | 9.426254e-3 |
GO:0051030 | snRNA transport | 9.431851e-3 |
GO:0002033 | vasodilation by angiotensin involved in regulation of systemic arterial blood pressure | 9.431851e-3 |
GO:0072161 | mesenchymal cell differentiation involved in kidney development | 9.458974e-3 |
GO:0060711 | labyrinthine layer development | 9.480363e-3 |
GO:0007032 | endosome organization | 9.510768e-3 |
GO:0021913 | regulation of transcription from RNA polymerase II promoter involved in ventral spinal cord interneuron specification | 9.584452e-3 |
GO:0032720 | negative regulation of tumor necrosis factor production | 9.898484e-3 |
GO:0071549 | cellular response to dexamethasone stimulus | 9.922579e-3 |
GO:0014866 | skeletal myofibril assembly | 1.002513e-2 |
GO:0034440 | lipid oxidation | 1.006087e-2 |
GO:0000432 | positive regulation of transcription from RNA polymerase II promoter by glucose | 1.013749e-2 |
GO:0022037 | metencephalon development | 1.014464e-2 |
GO:0030856 | regulation of epithelial cell differentiation | 1.015643e-2 |
GO:0035767 | endothelial cell chemotaxis | 1.018943e-2 |
GO:0030828 | positive regulation of cGMP biosynthetic process | 1.024902e-2 |
GO:0030011 | maintenance of cell polarity | 1.027132e-2 |
GO:0006405 | RNA export from nucleus | 1.045178e-2 |
GO:0050829 | defense response to Gram-negative bacterium | 1.046349e-2 |
GO:0042697 | menopause | 1.048159e-2 |
GO:0043697 | cell dedifferentiation | 1.048159e-2 |
GO:0032661 | regulation of interleukin-18 production | 1.048159e-2 |
GO:0002536 | respiratory burst involved in inflammatory response | 1.048159e-2 |
GO:0006917 | induction of apoptosis | 1.056845e-2 |
GO:0019285 | glycine betaine biosynthetic process from choline | 1.059249e-2 |
GO:0071318 | cellular response to ATP | 1.059249e-2 |
GO:0006383 | transcription from RNA polymerase III promoter | 1.059249e-2 |
GO:0010890 | positive regulation of sequestering of triglyceride | 1.059249e-2 |
GO:0090200 | positive regulation of release of cytochrome c from mitochondria | 1.082663e-2 |
GO:0060712 | spongiotrophoblast layer development | 1.083712e-2 |
GO:0051127 | positive regulation of actin nucleation | 1.087878e-2 |
GO:0045401 | positive regulation of interleukin-3 biosynthetic process | 1.087878e-2 |
GO:0045425 | positive regulation of granulocyte macrophage colony-stimulating factor biosynthetic process | 1.087878e-2 |
GO:0070318 | positive regulation of G0 to G1 transition | 1.089234e-2 |
GO:2000114 | regulation of establishment of cell polarity | 1.109992e-2 |
GO:0042403 | thyroid hormone metabolic process | 1.125437e-2 |
GO:2000095 | regulation of Wnt receptor signaling pathway, planar cell polarity pathway | 1.138931e-2 |
GO:0046903 | secretion | 1.165899e-2 |
GO:0061307 | cardiac neural crest cell differentiation involved in heart development | 1.166010e-2 |
GO:0034097 | response to cytokine stimulus | 1.184060e-2 |
GO:0045356 | positive regulation of interferon-alpha biosynthetic process | 1.195339e-2 |
GO:0072229 | metanephric proximal convoluted tubule development | 1.195339e-2 |
GO:0003340 | negative regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis | 1.195339e-2 |
GO:2000136 | regulation of cell proliferation involved in heart morphogenesis | 1.200416e-2 |
GO:0045989 | positive regulation of striated muscle contraction | 1.206806e-2 |
GO:0030902 | hindbrain development | 1.218000e-2 |
GO:0012502 | induction of programmed cell death | 1.245756e-2 |
GO:0034770 | histone H4-K20 methylation | 1.245857e-2 |
GO:0003416 | endochondral bone growth | 1.248581e-2 |
GO:0034105 | positive regulation of tissue remodeling | 1.265724e-2 |
GO:0006284 | base-excision repair | 1.268569e-2 |
GO:0040009 | regulation of growth rate | 1.279902e-2 |
GO:0019255 | glucose 1-phosphate metabolic process | 1.279902e-2 |
GO:0090184 | positive regulation of kidney development | 1.323105e-2 |
GO:0060215 | primitive hemopoiesis | 1.345768e-2 |
GO:0043547 | positive regulation of GTPase activity | 1.363454e-2 |
GO:0031943 | regulation of glucocorticoid metabolic process | 1.373239e-2 |
GO:0007220 | Notch receptor processing | 1.373239e-2 |
GO:0048505 | regulation of timing of cell differentiation | 1.377159e-2 |
GO:0072200 | negative regulation of mesenchymal cell proliferation involved in ureter development | 1.378589e-2 |
GO:0090191 | negative regulation of branching involved in ureteric bud morphogenesis | 1.378589e-2 |
GO:0072198 | mesenchymal cell proliferation involved in ureter development | 1.378589e-2 |
GO:0072192 | ureter epithelial cell differentiation | 1.378589e-2 |
GO:0090194 | negative regulation of glomerulus development | 1.378589e-2 |
GO:0072138 | mesenchymal cell proliferation involved in ureteric bud development | 1.378589e-2 |
GO:0072101 | specification of ureteric bud anterior/posterior symmetry by BMP signaling pathway | 1.378589e-2 |
GO:2000639 | negative regulation of SREBP-mediated signaling pathway | 1.378589e-2 |
GO:2000346 | negative regulation of hepatocyte proliferation | 1.378589e-2 |
GO:2000137 | negative regulation of cell proliferation involved in heart morphogenesis | 1.378589e-2 |
GO:2000007 | negative regulation of metanephric comma-shaped body morphogenesis | 1.378589e-2 |
GO:2000005 | negative regulation of metanephric S-shaped body morphogenesis | 1.378589e-2 |
GO:0007500 | mesodermal cell fate determination | 1.378589e-2 |
GO:0055020 | positive regulation of cardiac muscle fiber development | 1.378589e-2 |
GO:0050747 | positive regulation of lipoprotein metabolic process | 1.378589e-2 |
GO:0048392 | intermediate mesodermal cell differentiation | 1.378589e-2 |
GO:0006481 | C-terminal protein methylation | 1.378589e-2 |
GO:0060502 | epithelial cell proliferation involved in lung morphogenesis | 1.378589e-2 |
GO:0060503 | bud dilation involved in lung branching | 1.378589e-2 |
GO:0071893 | BMP signaling pathway involved in nephric duct formation | 1.378589e-2 |
GO:0061155 | pulmonary artery endothelial tube morphogenesis | 1.378589e-2 |
GO:0061151 | BMP signaling pathway involved in renal system segmentation | 1.378589e-2 |
GO:0061149 | BMP signaling pathway involved in ureter morphogenesis | 1.378589e-2 |
GO:0072097 | negative regulation of branch elongation involved in ureteric bud branching by BMP signaling pathway | 1.378589e-2 |
GO:0051453 | regulation of intracellular pH | 1.383606e-2 |
GO:0006167 | AMP biosynthetic process | 1.406583e-2 |
GO:0045074 | regulation of interleukin-10 biosynthetic process | 1.414931e-2 |
GO:0045423 | regulation of granulocyte macrophage colony-stimulating factor biosynthetic process | 1.419985e-2 |
GO:0008156 | negative regulation of DNA replication | 1.423971e-2 |
GO:0001840 | neural plate development | 1.449781e-2 |
GO:0042048 | olfactory behavior | 1.452729e-2 |
GO:0009258 | 10-formyltetrahydrofolate catabolic process | 1.452729e-2 |
GO:0030070 | insulin processing | 1.452729e-2 |
GO:0090072 | positive regulation of sodium ion transport via voltage-gated sodium channel activity | 1.457664e-2 |
GO:0071104 | response to interleukin-9 | 1.471033e-2 |
GO:0052063 | induction by symbiont of defense-related host nitric oxide production | 1.471033e-2 |
GO:2000001 | regulation of DNA damage checkpoint | 1.471033e-2 |
GO:0002551 | mast cell chemotaxis | 1.471033e-2 |
GO:0040040 | thermosensory behavior | 1.471033e-2 |
GO:0042892 | chloramphenicol transport | 1.471033e-2 |
GO:0032321 | positive regulation of Rho GTPase activity | 1.476175e-2 |
GO:0034332 | adherens junction organization | 1.501425e-2 |
GO:0002862 | negative regulation of inflammatory response to antigenic stimulus | 1.502207e-2 |
GO:0002218 | activation of innate immune response | 1.510478e-2 |
GO:0051918 | negative regulation of fibrinolysis | 1.549644e-2 |
GO:0060125 | negative regulation of growth hormone secretion | 1.566672e-2 |
GO:0071217 | cellular response to external biotic stimulus | 1.566672e-2 |
GO:0080164 | regulation of nitric oxide metabolic process | 1.566672e-2 |
GO:0051792 | medium-chain fatty acid biosynthetic process | 1.566672e-2 |
GO:0070684 | seminal clot liquefaction | 1.566672e-2 |
GO:0009443 | pyridoxal 5'-phosphate salvage | 1.566672e-2 |
GO:0051463 | negative regulation of cortisol secretion | 1.566672e-2 |
GO:0035509 | negative regulation of myosin-light-chain-phosphatase activity | 1.566672e-2 |
GO:0043378 | positive regulation of CD8-positive, alpha-beta T cell differentiation | 1.566672e-2 |
GO:0002223 | stimulatory C-type lectin receptor signaling pathway | 1.566672e-2 |
GO:0032320 | positive regulation of Ras GTPase activity | 1.578544e-2 |
GO:0010623 | developmental programmed cell death | 1.584564e-2 |
GO:0010951 | negative regulation of endopeptidase activity | 1.588745e-2 |
GO:0009948 | anterior/posterior axis specification | 1.593392e-2 |
GO:0072210 | metanephric nephron development | 1.607449e-2 |
GO:0051186 | cofactor metabolic process | 1.612371e-2 |
GO:0070542 | response to fatty acid | 1.615080e-2 |
GO:0031532 | actin cytoskeleton reorganization | 1.685896e-2 |
GO:0035865 | cellular response to potassium ion | 1.690927e-2 |
GO:0060381 | positive regulation of single-stranded telomeric DNA binding | 1.690927e-2 |
GO:0071896 | protein localization to adherens junction | 1.690927e-2 |
GO:0090274 | positive regulation of somatostatin secretion | 1.690927e-2 |